Medical technology and pharmaceutical companies are looking forward to a promising future. Technological innovation and excellence in pharmacological research are enabling increasingly successful treatments.
However, few industries face such historic challenges. The general digitization trend is accompanied by a range of industry-specific issues that will lead to fundamental changes in the coming years. Exploding healthcare costs, combined with enormous quality and efficiency pressures, tightening regulatory frameworks, and other factors, are forcing companies to constantly reassess and realign their traditional business models and corporate strategies.
In this challenging scenario, companies in the healthcare industry need innovative strategies and top executives who can drive and actively shape the associated changes.